Transgenic expression of human S100A12 induces structural airway abnormalities and limited lung inflammation in a mouse model of allergic inflammation.
Transgenic expression of human S100A12 induces structural airway abnormalities and limited lung inflammation in a mouse model of allergic inflammation.
复制标题
DOI:
10.1111/j.1365-2222.2011.03714.x
复制
发表时间:
2011-06
期刊:
影响因子:
--
通讯作者:
Camoretti-Mercado B
中科院分区:
文献类型:
--
作者:
Hofmann Bowman MA;Heydemann A;Gawdzik J;Shilling RA;Camoretti-Mercado B
The calcium binding protein S100A12 is highly upregulated in the serum and sputum of patients with allergic asthma and is suggested to be a biomarker and pathologic mediator of asthma. To test the role of S100A12 in mediating airway inflammation in a mouse model of allergic lung inflammation. Transgenic mice that express human S100A12 and wild type littermates were sensitized and challenged with ovalbumin and assessed for inflammation, lung structure and function. Following ovalbumin sensitization and challenge, S100A12 transgenic mice showed reduced peribronchial and perivascular inflammation, mucus production and eosinophilia as well as attenuated airway responsiveness to contractile agonist compared to wild type sensitized and challenged animals. This is explained, at least in part, by remodeled airways in S100A12 transgenic mice with thinning of the airway smooth muscle. S100A12 exposure induced Fas expression and activation of caspase 3 in cultured airway smooth muscle cells, suggesting that airway smooth muscle abnormalities observed in S100A12 transgenic mice may be mediated through myocyte apoptosis. S100A12 is one of the most abundant proteins found in the airways of human asthmatics, and it was postulated that S100A12 could mediate the inflammatory process. Our study shows for the first time that transgenic expression of S100A12 in the lung of mice does not exacerbate lung inflammation in a model of ovalbumin-induced allergic inflammation. We speculate that the high levels of S100/calgranulins found in BALF of asthmatics and of ovalbumin-treated transgenic S100A12 mice do not significantly mediate pulmonary inflammation.
登录
查看更多内容
影响因子:
20.1
作者:
Hofmann Bowman M;Wilk J;Heydemann A;Kim G;Rehman J;Lodato JA;Raman J;McNally EM
通讯作者:
McNally EM
影响因子:
15.9
作者:
Harja, Evis;Bu, De-Xiu;Schmidt, Ann Marie
通讯作者:
Schmidt, Ann Marie
影响因子:
3.4
作者:
Calvo, Florence Quesada;Fillet, Marianne;Cataldo, Didier
通讯作者:
Cataldo, Didier
影响因子:
4
作者:
Kumar, RK;Foster, PS
通讯作者:
Foster, PS
影响因子:
30.8
作者:
Cookson, WOCM;Ubhi, B;Harper, JI
通讯作者:
Harper, JI